US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
NASDAQ
Eupraxia Pharmaceuticals Inc (EPRX) 銘柄情報

Eupraxia Pharmaceuticals Inc (EPRX)

5.95

-0.50

(-7.75%)

終了 6月7日 5:00AM

5.965

0.015

(0.25%)

取引時間後: 8:59AM

Eupraxia Pharmaceuticals Inc (EPRX) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

5.95

( -7.75% )

買値

5.94

売値

8.06

出来高

356,567

5.93 日の範囲 6.48

3.85 52 週間の範囲 9.32

時価総額

前日終値

6.45

始値

6.48

時刻

最終取引時間

財務取引量

US$ 2,195,462

VWAP

6.1572

平均取引量 (3 か月)

US$ 64,271

発行済株式数

65,326,947

配当利回り

PER

-7.11

1 株当たり利益 (EPS)

-1.04

歳入

-

純利益

-44.47M

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company’s produ... Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company’s product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.eupraxiapharma.com

本社

Victoria, Canada

設立

2026

Eupraxia Pharmaceuticals Inc is listed in the Healthcare sector of the ナスダック市場 with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was US$6.45. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of US$ 3.85 to US$ 9.32.

Eupraxia Pharmaceuticals currently has 65,326,947 shares in issue. The market capitalisation of Eupraxia Pharmaceuticals is US$388.70 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.11.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.43	-19.3766937669	7.38	7.51	5.965	278008	6.63184974	CS
4	-1.53	-20.4545454545	7.48	7.83	5.965	257286	6.89321953	CS
12	-1.51	-20.2412868633	7.46	8.13	5.965	213585	7.1297918	CS
26	0.01	0.16835016835	5.94	9.32	5.8726	208362	7.60213113	CS
52	2.0587	52.9051987768	3.8913	9.32	3.85	140404	7.14324127	CS
156	2.4	67.6056338028	3.55	9.32	2.2	73181	6.70245114	CS
260	2.4	67.6056338028	3.55	9.32	2.2	73181	6.70245114	CS

EPRX - Frequently Asked Questions (FAQ)

What is the current Eupraxia Pharmaceuticals Inc share price?

The current share price of Eupraxia Pharmaceuticals Inc is US$ 5.95

How many Eupraxia Pharmaceuticals Inc shares are in issue?

Eupraxia Pharmaceuticals Inc has 65,326,947 shares in issue

What is the market cap of Eupraxia Pharmaceuticals Inc?

The market capitalisation of Eupraxia Pharmaceuticals Inc is USD 388.7M

What is the 1 year trading range for Eupraxia Pharmaceuticals Inc share price?

Eupraxia Pharmaceuticals Inc has traded in the range of US$ 3.85 to US$ 9.32 during the past year

What is the PE ratio of Eupraxia Pharmaceuticals Inc?

The price to earnings ratio of Eupraxia Pharmaceuticals Inc is -7.11

What is the registered address of Eupraxia Pharmaceuticals Inc?

The registered address for Eupraxia Pharmaceuticals Inc is 2067 Cadboro Bay Road, Victoria, British Columbia, V8R 5G4

What is the Eupraxia Pharmaceuticals Inc website address?

The website address for Eupraxia Pharmaceuticals Inc is www.eupraxiapharma.com

Which industry sector does Eupraxia Pharmaceuticals Inc operate in?

Eupraxia Pharmaceuticals Inc operates in the Biotechnology & Life Sciences sector

PuzzleRealm18

PuzzleRealm18 10分前

This company will be profitable in Q2 we will probably break 15$ and have a buy out around 18$

ron_66271

ron_66271 21分前

The Same Holds True For F&F.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177679893

Therefore even Government Agencies.

11,000 redacted documents by BO.

Ron

Genz2

Does Elon think that it is more important to spend billions of dollars on sending someone to Mars with the very remote possibility that they survive the trip within the next 50 years or to be able to spend billions on feeding poor people with the possibility that one person could turn into the next

ron_66271

ron_66271 22分前

This Is Significant!!

I posted this on the other F&F MB.

Hence;
The Sherman Act that was part of the litigation against FDIC for the 5AT.

Plus the RICO allegations against JPM which was settled in meditation with Judge Lyons.

ron_66271

ron_66271 44分前

The Same Holds True For F&F.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177679893

Therefore even Government Agencies.

11,000 redacted documents by BO.

Ron

nowwhat2

nowwhat2 44分前

https://investorshub.advfn.com/uimage/uploads/2026/6/7/l[pkpBTC_JUNE_6_10d_1130pm_STICKMAN_SEES_200_BO.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/7/gsodfbtc_june_6_snip_11pm_200_BO_61818_W_STICK.jpg

https://investorshub.advf

nowwhat2

nowwhat2 1時間前

Project Nahoonai as an example of how Canada can contribute to the global SAF transition.” said Matt Scorah, incoming Chief Development Officer. “By transforming underutilized biomass into low-carbon aviation fuel and integrating carbon capture and storage, we believe Project Nahoonai represents a p

jeunke22

jeunke22 1時間前

It’s a privilege to witness the depth and qualitative analysis many posters bring to this board.
Yes, predictions are not always turning out right since we need alignment of minds and circumstances to make that happen.
One thing is crystal clear and undeniable, Lightwave is going to be

raiderz

raiderz 1時間前

HIRU is like a jigsaw puzzle and you get a few pieces every couple of months.

That email from Ghazi is pure gold, and the satman’s analysis is 💯

It confirms the suspicion they tend to stop paying their lawyers. As we can see now, that’s a terrible idea.

Dorick

Dorick 1時間前

Mr. Bystander - I'm very sorry if I seemed condescending - that was not my intention at all, and I've never suggested that you are anything other than perfectly intelligent. Thanks ever so much for saying you'll "likely file the complaint" - that means the world to me!
https://fraudcraftjourn

dinogreeves

dinogreeves 1時間前

When Tellurian went public in February 2017 through a reverse merger with Magellan Petroleum, the former (private) Tellurian Investments shareholders held approximately 96% of the combined company's pro forma outstanding stock. Conversely, the legacy (minority) Magellan shareholders retained roughly

dinogreeves

dinogreeves 1時間前

NextDecade went public on July 24, 2017, through a reverse merger with a Special Purpose Acquisition Company (SPAC), Harmony Merger Corp. Upon the closing of the business combination, Harmony's public and minority shareholders owned approximately 13.0% of the combined company. The remaining majority

dinogreeves

dinogreeves 2時間前

During the 2018 merger between Cheniere Energy, Inc. and Cheniere Energy Partners LP Holdings, LLC (ticker: LNG), approximately 97.6% of total outstanding common shares approved the merger.Specifically for the publicly-held shares that Cheniere Energy didn't already own, the approval rate was about

Genz2

Genz2 2時間前

https://www.thestreet.com/investing/stocks/goldman-sachs-aggressively-resets-crowdstrike-stock-price-target-after-earnings

If Crowdstrike can’t really be successful in stopping breaches over the last 10 years given the tens of thousands of data breaches there were, then why should we

thistraderknowsall

thistraderknowsall 2時間前

Ok next up..KABOOOOOM.. DEGEN Crypto surges to $23 like RAVE did in April.. #1 next runner-up! Congrats! DEGEN !!!

sometimes_right

sometimes_right 2時間前

Are the stars aligning???

Lehman Brothers Financial SA (LEHNQ)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177679846
cottonisking Sunday, June 07, 2026 12:14:46 AM Post# 116336

This Supreme Court ruling is a major victory for the SEC (S

walterc

walterc 2時間前

th6565. what is your nationality?

Truenorth2016

Truenorth2016 2時間前

Yes, LOL, and BIEI is supporting it......Unfortunately, Global War is here to stay! Its not ever going anywhere to the point its a Billion(S) Dollar Business.
Other countries hide their Department of War under the title "Ministry of Defense", etc. Any Country with a Military has a Defense De

satter

satter 2時間前

The HIRU Expert Translator Needed ( see below ) For mascale 🫠

https://share.google/OA8MFYcJvWqDOUrFH

TieetCoolee

TieetCoolee 2時間前

47 knows what the privatization terms are, Certainly.
the ceiling depends entirely on privatization terms that remain uncertain.

$FMCC~ $FNMA~

Investor082

Investor082 2時間前

None of the fluff updates around Flaskworks or C lab construction matters at this time. It will just be construed as a desperate move and UK decision being far away. So expect more selling.

Only UK decision and significant non dilutive funding news count at this point. Otherwise, Gar

barnstormer

barnstormer 2時間前

Doc, I got tired of all the arguing over the Flaskworks progress, so decided to try to do an AI updated version. Fed in the Feb 2924 PR, the Dec 2025 ASM and a couple of items that weren't mentioned in them. Spent the best part of an hour challenging and rechallenging its output, finally asked for a

Investor082

Investor082 2時間前

Its only going to get worse, but be prepared to close the year between 1.95 to 2B outstanding shares.

Investor082

Investor082 2時間前

This has been flipper’s strategy for 12+ years to throw tantrums every now and then to appear genuine, but don’t fall for it. His job is to trap bag holders by coming up with BS theories, setting false expectations, and that will continue for the foreseeable future.

Just wait and wat

DocLee

DocLee 2時間前

".... and that [of] MHRA, are reasonably subject to scrutiny." I am sure the the MHRA are already aware of Parliament's hot breath down the back of their collective necks following Sir Iain Duncan Smith's parliamentary questions pertaining to DCVax-L in March this year. I would also imagine that

Eupraxia Pharmaceuticals

Antipa Minerals

Desktop - Sigmanet Comun... ON

Leverage Shares -1x Tsla

Hertiage Crystal Clean

BNP Paribas Easy II MSCI...

Horizon Minerals

IN XTK MSCI EMUCLITREO

0913693 BC (EM)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。